Skip to content
value.today

Catalyst OrthoScience Inc

🇺🇸 Naples, Florida, USABiotechnologyFounded 2017
Total raised
$25 M
4 rounds on record
Latest round
$4 M
Jul 2025
First round on record
Nov 2017
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Catalyst OrthoScience Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2025$4 MNo. 4$2 to $10 million

Catalyst OrthoScience Inc: Raise no. 4, Jul 2025

Investors in this round

3 investors had bought by the notice of Jul 31, 2025: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $6 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Carl O'Connell · Executive Officer, Director
  • Carter McNabb · Director
  • Dan Fleming · Director
  • Derace Schaffer · Director
  • Wayne Wallace · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Carl O'Connell, Ceo. Source: SEC Form D, newest notice filed Jul 31, 2025. Read the notice at the SEC.

equitySEC
Apr 2024$2 MNo. 3Under $2 million

Catalyst OrthoScience Inc: Raise no. 3, Apr 2024

Investors in this round

2 investors had bought by the notice of Apr 18, 2024: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Carl O'Connell · Executive Officer, Director
  • Cameron S. Rubino · Director
  • Carter McNabb · Director
  • Dan S. Fleming · Director
  • Derace S. Schaffer · Director
  • Steven S. Goldberg · Director
  • Wayne Wallace · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Carl O'Connell, Ceo. Source: SEC Form D, newest notice filed Apr 18, 2024. Read the notice at the SEC.

equitySEC
May 2023$15 MNo. 2$10 to $50 million

Catalyst OrthoScience Inc: Raise no. 2, May 2023

Investors in this round

81 investors had bought by the notice of Sep 7, 2023: 81 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Carl O'Connell · Executive Officer, Director
  • Carter McNabb · Director
  • Derace Schaffer · Director
  • Steven Goldberg · Director
  • Wayne Wallace · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Carl O'Connell, Ceo. Source: SEC Form D, newest notice filed Sep 7, 2023. Read the notice at the SEC.

equitySEC
Nov 2017$4 MNo. 1$2 to $10 million

Catalyst OrthoScience Inc: Raise no. 1, Nov 2017

Investors in this round

26 investors had bought by the notice of Nov 29, 2017: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert Kaufman · Executive Officer, Director
  • David L Wood · Director
  • Derace L Schaffer · Director
  • Steven S Goldberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Kaufman, CEO and Chairman. Source: SEC Form D, newest notice filed Nov 29, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Catalyst OrthoScience Inc chose not to state its revenue in its newest notice of a funding round (Jul 2025).

    SEC Form D · Jul 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2025

That is all the official record says: Catalyst OrthoScience Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Catalyst OrthoScience Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 81 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Catalyst OrthoScience Inc
NameRoleNamed in
Carl O'ConnellExecutive officerJul 2025
Robert KaufmanExecutive officerNov 2017
Carl O'ConnellDirectorJul 2025
Carter McNabbDirectorJul 2025
Dan FlemingDirectorJul 2025
Derace SchafferDirectorJul 2025
Wayne WallaceDirectorJul 2025
Cameron S. RubinoDirectorApr 2024
Dan S. FlemingDirectorApr 2024
Derace S. SchafferDirectorApr 2024
Steven S. GoldbergDirectorApr 2024
Steven GoldbergDirectorSep 2023
David L WoodDirectorNov 2017
Derace L SchafferDirectorNov 2017
Robert KaufmanDirectorNov 2017
Steven S GoldbergDirectorNov 2017